- Report
- January 2025
- 82 Pages
Vietnam
From €3234EUR$3,500USD£2,709GBP
- Report
- January 2025
- 83 Pages
Vietnam
From €3234EUR$3,500USD£2,709GBP
- Report
- December 2024
- 80 Pages
India
From €3234EUR$3,500USD£2,709GBP
- Report
- December 2024
- 82 Pages
India
From €3234EUR$3,500USD£2,709GBP
- Report
- September 2024
- 82 Pages
Japan
From €3234EUR$3,500USD£2,709GBP
- Report
- September 2024
- 82 Pages
Japan
From €3234EUR$3,500USD£2,709GBP
- Report
- August 2024
- 82 Pages
Japan
From €3234EUR$3,500USD£2,709GBP
- Report
- July 2024
- 180 Pages
Global
From €4158EUR$4,500USD£3,482GBP
- Report
- October 2023
- 90 Pages
United States
From €3234EUR$3,500USD£2,709GBP
- Report
- August 2023
- 74 Pages
Canada
From €3234EUR$3,500USD£2,709GBP
- Report
- September 2025
- 70 Pages
India
From €3234EUR$3,500USD£2,709GBP
- Report
- September 2025
- 70 Pages
India
From €3234EUR$3,500USD£2,709GBP
- Report
- September 2025
- 88 Pages
India
From €3234EUR$3,500USD£2,709GBP
- Report
- September 2025
- 70 Pages
India
From €3234EUR$3,500USD£2,709GBP
- Report
- September 2025
- 70 Pages
India
From €3234EUR$3,500USD£2,709GBP
- Report
- September 2025
- 70 Pages
India
From €3234EUR$3,500USD£2,709GBP
- Report
- September 2025
- 88 Pages
India
From €3234EUR$3,500USD£2,709GBP
- Report
- September 2025
- 88 Pages
India
From €3234EUR$3,500USD£2,709GBP
- Report
- September 2025
- 88 Pages
India
From €3234EUR$3,500USD£2,709GBP
- Report
- September 2025
- 70 Pages
India
From €3234EUR$3,500USD£2,709GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more